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Keratinocytes have recently been recognized as a 
source of mediators of cellular immune function. We 
present here further data on the production of 5-lipox-
ygenase-dependent arachidonate metabolites from 
freshly isolated human epidermal cells. Stimulation of 
cells with arachidonic acid or the calcium ionophore A 
23187 alone or together caused a dose- and time-depen-
dent release of chemotactic activity which was maximal 
during the first 10 min and which continued for up to 
18 h . Indomethacin (10-6 M) enhanced and compound 
BW 755C (20 J.Lg/ml), a lipoxygenase inhibitor, de-
creased release. The chemotactic activity was heat sta-
ble for 30 min at 56°C and was extractable into ether at 
pH 3.0. Analysis of 15- and 30-min supernatants showed 
coelution of biologic activity and of leukotriene B 4 
(LTB4), as measured by radioimmunoassay, at marker 
positions of L TB. and of 20-0H-L TB.1• Elimination of 
Langerhans cells did not alter the secretion of chemo-
tactic lipids, suggesting that keratinocytes are the main 
source of potent, biologically active, lipoxygenase-
dependent arachidonate metabolites. 
In recent years, leukotrienes have been identified as potent 
inflammatory and immunomodulatory lipid mediators [1- 3]. 
They are generated from arachidon ic acid (aa) via a 5-lipoxy-
genase enzyme after stimulation of a wide range of cells, in-
cluding polymorphonuclear leukocytes, monocytes/macro-
phages, and mast cells [1 ,2,4]. 
The epidermis consists of two cell types that play a prominent 
role in the immunologic defense of the host: the Langerhans 
cell , a dendritic cell that functions in antigen recognition and 
processing, and the keratinocyte, which is t he source of im-
munomodulatory mediators, such as epidermal thymocyte ac-
tivating factor (ETAF), a molecule that closely resembles in-
terleukin 1 [5). Guinea pig keratinocytes have also been shown 
to produce aa-derived prostaglandins and monohydroxyeico-
satetraenoic acids (HETE) [6,7]. 
In a previous brief communication [8], we reported on the in 
vitro generation of chemotactic lipoxygenase products of aa 
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from human keratinocytes, confirming t he data reported in 
abstract form by Brain eta! several years ago [9]. In the present 
investigation, we present further details on the in vitro secre-
tion of chemotactic diHETEs such as leukotriene B, (L TB,) 
from human epidermal cells. Stimuli that might induce secre-
tion of these substances were chosen from methods published 
for other cell types [1,2] . Experiments were also performed to 
identify the exact cell source of the mediators among epidermal 
cells. Finally, the nature of the secretory process and the 
chemical nature of the compounds produced were more closely 
scrutinized by pharmacologic and analytic methods. 
MATERIALS AND METHODS 
Human epidermal cells were isolated from freshly excised normal 
human skin obtained from amputat ions or melanoma operations. Nar-
row strips of the skin were incubated for 1 h at 37"C with t rypsin , 0.5% 
(Sigma, Mun ich, F.R.G. ). The epidermis was then separated from the 
dermis with fine forceps, gently homogenized in a Potter-Elvejehm 
device, briefly exposed to desoxyribonuclease 0.025% (Boehringer, 
Mannheim, F.R.G.) , and washed twice in RPMI buffer (Seromed, 
Munich, F.R.G.). Viabi lity of cells, as determined by eosin Y (0.02% ) 
staining of cells within 1 min, ranged from 50-80%. The isolation of 
cells lasted for 4-5 h. 
In order to study the role of Langerhans cells in the production of 
mediators, epidermal cell suspensions (1 X 107 viable cells/ ml) were 
incubated with a monoclonal antibody that had OKT6 specificity (a 
gift of Dr. J. DeVries, Amsterdam, The Netherlands) at a concentration 
of 0.005 mg/ ml for 1 h on ice. The cells were then washed and exposed 
to rabbit complement (Cedarlane, Hornby, Canada) at a dilution of 
1:15 for another hour, 37"C. Control cells were t reated identically, 
except for the omission of OKT6. The presence of Langerhans cells 
was checked with the OKT6 a ntibody by the immunoperoxidase tech-
nique [10]. 
Release of mediators was studied by incubating 1 x 107 viable cells 
per ml RPMI medium at 37"C for varying times with buffer alone, in 
combination with, or alone with the calcium ionophore A 23187 (Ion), 
10- 5 to 10- 7 M (a gift of Dr. R. Hamill , St . Louis, Missouri), with aa, 
10- 3 to 10-6 M (Sigma) , and with (3H] aa, 15 J.LCi/ml (about 1 x 10- •o M 
aa) (Amersham, Braunschweig, F.R.G .). In 4 experiments, cells were 
preincubated for 10 min at 37"C with indomethacin (Sigma), 10-5 to 
10-s M, or with compound BW 755C, 20 J.Lg/ ml (a gift of Dr. R. J. 
Flowers, London). Details of these methods have been described in 
studies with ot her cell types [11,12]. Indomethacin and compound BW 
755C had no effect on the chemotaxis assay at the concentrations 
tested (1 3]. 
Reverse-phase high-pressure liquid chromatography (RP-HPLC) 
was performed wi th a Waters Associated system (Milford, Massachu -
setts, U.S.A). Synthetic L TB, III (6,8,10-ci:S , 58, 12 R diHETE) , 20-
0H-LTB,, 20-COOH-LTB, (from Dr. R. J. Rokach, Montreal , Ca n-
ada), (3H-L TB, (Amersham) , 6,8,10-trans, 58, 12R diHETE (LTB, 1) , 
6,8,10 trarJ.S, 58, 128-diHETE (LTB,-11), 15-HETE and 12-HETE 
(from Dr. G. Loschen, Aachen, F.R.G.) served as markers. Keratinocyte 
supernatants were extracted into ether , pH 3.0, were evaporated, re-
suspended in methanol:water, 69:31, pH 5.7, and were eluted in t he 
same solvent from a LiChrosorb RP 18 column (5 p.m) (Merck, Darms-
tadt, F.R.G.). The flow rate was 0.5 ml/ min. The frac tions of the eluant 
were evaporated, reconstituted in RPM! buffer , adjusted to pH 7.4, a nd 
assayed for biologic activity. The extraction procedure, with PGB2 as 
standard, caused a 30- 76% loss of material. In samples with labeled 
compounds, radioactivity was measured by routine methods. 
The L TB, radioimmunoassay (RIA) was performed, as previously 
described [14], and the reagents were purchased from Wellcome Diag-
nostics, Dartford, England. The assay is highly specific for L TB, a nd 
its metabolites, with a small cross-reactivity for aa (< 0.03%), t he 
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mono-HETEs (0.03- 2% ), and the diastereomere of 5,12-dihydroxy-
6,8,1 0-trans-14-cis-eicosatetraeonic acid (3.3%). 
In vitro chemotax is was studied with human or guinea pig peri toneal 
leukocytes in modified Boyden chambers [11]. Both cell types yielded 
comparable results. L TB,, w-s M, served as standard in each assay. 
Resu lts are expressed as the number of cells that have migrated through 
t he filters in 5 random high-power microscopic fie lds (HPF) (400x). 
Data are given as mean ± SD of quadruplicate samples. 
RESULTS 
Kinetics of the release of chemotactic activity from isolated 
human epidermal cell suspensions were performed with cells 
from 12 different donors. Fig 1 shows data from one such 
experiment. There was a moderate amount of spontaneous 
release with time (C) which was always present but varied in 
quantity from donor to donor. On stimulation with the Ion or 
aa, chemotactic activity in cell supernatants increased mark-
edly. Stimulation with both stimuli had an additive effect. 
Optimal stimulation occurred always within the first 10 min 
and occasionally for up to 30 min , with only small additional 
activity being released for up to 18 h (Fig 1). 
On comparison of the kinetics of stimulated release from 
cells of different donors with the L TB., w-B M, standard during 
in vitro chemotaxis, the biologic activity of the 10-min super-
natants had a mean of 87% (range 3-245%) of the LTB4 
standard . By 30 min, the mean activity was 32% (range 4-89%) 
and at 18 h, it was 33% (range 5-71 %). 
The responsiveness of cells to the stimuli differed from donor 
to donor. Ion or aa, when tested in the bioassay at the concen-
trations that were present in the keratinocyte supernatants, 
caused no chemotaxis of cells above buffer controls. 
At a concentration of 10- 6 M, release with Ion was optimal, 
and lower or higher doses were less effective. For aa, optimal 
stimulation occurred at 10-3 and w-·j M (not shown). Higher 
doses were not tested and lower doses were far less effective. 
In all routine experiments, stimulation was therefore done with 
Ion, 10- 6 M and aa, 10- 4 M . 
The role of the cyclooxygenase and lipoxygenase enzymes in 
the production of chemotactic activi ty from keratinocytes was 
studied in 4 different experiments by preincubation of cells 
with enzyme inhibitors. Indomethacin, at 10- 6 M, caused a 
marked enhancement of biologic activity which was seen to a 
lesser degree at 10- 7 and w-R M (Table I) . Compound BW 
755C, at concentrations that inhibit neutrophil lipoxygenase 
(20 JLg/ml) (12,15], also dec reased epidermal cell-derived chem-
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FIG 1. Representative experiment, showing the kinetics of the re-
lease of chemotactic factor (cells/5 HPF) from 1 X 107 epidermal cells/ 
ml, incubated at 37"C. At each point in time shown, the cells were 
centrifuged in the cold and new buffer with or without the stimulus 
was added. The data show the cumulative biologic activity that was 
secreted over the entire prev ious incubation time. Similar data were 
obtained in 12 other experiments. x--x = Buffer alone; -- = 
Ion, 10- 6 M; 0--.Q = aa, 10_,, M; .__.. = aa 10-4 M and Ion 10-6 M 
combined. 
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atactic factor generation (Table 1). The inhibition was more 
effective when the secretory activity of the cells was lower. 
Unstimulated release of chemotactic activity was also inhibited 
by BW 755C. 
In order to examine whether keratinocytes or Langerhans 
cells are the source of epidermal cell-derived chemotactic activ-
ity, fresh ly isolated epidermal cells were preincubated with 
either complement alone or with complement and OKT6 to-
gether (a total of 11 experiments). After immunoperoxidase 
staining, Langerhans cells constituted 3-5% of the total epi-
dermal cells (Fig 2), and they were no longer detectable in cell 
suspensions treated with OKT6 and complement (not shown). 
Bo~h. cell prepar~tions yiel~ed comparable amounts of biologic 
act1v1ty when stimulated wtth Ion and aa under standard con-
ditions. On RP-HPLC analysis, the peaks at marker positions 
for LTJ?, wer~ of equal size for the supernatants (not shown). 
Heatmg o! the keratmocyte supernatants for 30 min at 
56"C caused no decrease of biologic activity. On extraction of 
the supernatants into ether, pH 3.0, all chemotactic activity 
separated into the organic phase (not shown). 
RP-HPLC chromatograms of epidermal cell supernatants 
sh?wed . peaks at the ~arker positions as well as at many 
umdentJfied polar peaks m both early and long-term incubation 
mixtures. As is illustrated in Fig 3, chemotactic activity was 
noted in several fractions in the region of the marker position 
for LTB, and at the position of 20-0H-LTB, in 30-min cell 
supernatants. Similar results were obtained with 10-min and 
TABLE I. Effect of the cyclooxygen.ase inhibitor indomethacin an.d the 
lipoxygenase inhibitor B W 755C on the generation of chemotactic 
activity from human keratinocytes, stimulated with arachidonic acid, 
10-• M and calcium ion.ophore A 23 187, 10-6 M for 15 min. 
Inhibitor 
Indomethacin 10 6 M 
10-7 M 
w-s M 
BW 755C,20 11g/ ml 
c 
Chemotact ic activity in superna tants 
(cells/5 HPF) 
1295 ± 124 
406 ± 31 
289 ± 22 
28 ± 9 
148 ± 17 
Chemotactic activity is expressed as mean ± 1 SD of 5 different 
re~dings in the assay. Note the enhancement of activity by indometh-
acm and the inhibition by BW 755C, compared to controls (C). 
Ftc 2. Light microscopy of epidermal cell suspensions stained with 
OKT6 and horseradish peroxidase to identify Langerhans cells (see 
darkly stained cells). The remaining cells are keratinocytes at varying 
stages of differentiation . No peripheral polymorphonuclear leukocytes 
were ever noted in these preparations. 
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FIG 3. a, Marker curve for the RP-HPLC elution profile. One 
hundred nanograms of LTB.,-COOH, 100 ng of PGB2, 77 ng of LTB,-
OH, 53 ng of L TB, I (6-trans , 58, 12R diHETE) , 150 ng of LTB, II (6-
trans, 58, 128-dii-IETE) , 48 ng of L TB, III (6-cis, 58, 12R diHETE) , 
25 ng of 15-HETE, 63 ng of 12-HETE, and [3H]LTB, III (0.2 11Ci) 
were applied alone and also as a mixture to the column. UV absorbance 
is shown as solid lines and radioactivity as dotted lines. b, RP-HPLC 
elution profile of keratinocyte supernatants, after a 30-min incubation 
with aa w-• M and 15 11Ci/ml of aa (10- 10 M). Two milliliters of t he 
crude supernatant had been evaporated and app lied to the column. 
Column fractions were again evaporated and reconstituted in 2 ml, 500 
J-Li of which was tested in the chemotaxis assay. Results are shown as 
UV absorbance (solid lines ), as dpm x 10 (dotted lines), and as cells/ 5 
HPF in the chemotax is assay. The L TB, standard oo-• M) in the same 
bioassay yie lded a mean chemotactic activity of 880 cells/5 HPF. 
18-h supernatants. In unstimulated cell supernatants, a small 
peak with chemotactic activity was noted at the marker position 
for L TB.1 (not shown). 
RP-HPLC chromatograms of supernatants from epidermal 
cells that had been incubated with 15 11Ci [3H)aa (1 X 10- to M 
aa) in addition to the standard stimuli, showed a peak of 
radioactivity at the marker position of [3H)LTB, which eluted 
earlier than LTB, (Fig 3b). Radioactivity was also noted at 
several unidentified positions, indicating that compounds with 
both higher and lower polarities had been labeled. 
In the L TB .. RIA, activity was measured in supernatants of 
keratinocytes after stimulation with aa 10_,, M and more so 
with Ion and aa 10-·l M, in correspondence to the results in the 
chemotaxis assay. When the background due to added aa, as 
measured separately, was subtracted from the counts , the L TB4 
activity in the aa- and Ion-stimulated keratinocyte superna-
tants was 2.8 ng/ml at 10 mi11 and 3.8 ng/ml at 18 h. 
Fig 4 shows the elution profile of a 15-min keratinocyte 
supernatant and the ng/ml quantity of the L TB, standard, as 
measured in the RIA. The sum of t he measurements in the 
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FIG 4. RP-HPLC profile of keratinocyte supernatants after stimu-
lation of 1 X 10 viable cells for 15 min , 37"C, with aa w-• M and 
ionophore 10-6 M as stimulus. Data for the L TB, in the fractions, as 
measured by RIA, are shown in the bar graphs (ng/ ml). The UV 
absorbance is shown in solid lines. Note the broad range of LTB,, as 
measured in the RIA, also at the position of the LTB, isomer (Fig 3a). 
fractions was 1.066 ng L TB,/ml, while 13 ng/ml L TB. was 
measured in the same unextracted keratinocyte supernatant 
prior to elution. 
DISCUSSION 
The data presented here provide several lines of evidence 
that keratinocytes serves as source of 5-lipoxygenase-depen-
dent chemotactic arachidonate metabolites. This suggests that 
keratinocytes are able to initiate and maintain inflammatory 
processes of the skin through the generation of potent chemo-
tactic mediators. 
The release of this chemotactic activity is stimulus-, time-, 
and dose-dependent. Maximal secretion occurs after 5-10 min 
of stimulation which corresponds to the kinetics described for 
human leukocytes [1,11). The cells are, however, able to gen-
erate more activity over another 18 h of stimulation (Fig 1). 
The secretion of chemotactic activity by keratinocytes is 
dependent on the type and dose of the stimulus applied. Cells 
exhibit variations in their responsiveness to different stimuli 
in different experiments which may be donor-dependent or due 
to differences in handling of the cells from experiment to 
experiment. This point could not be clarified since skin from 
the same donor was not available for repeated testing. The 
spontaneous release, as observed to a varying degree with 
practically all cells, may be due to the interaction of living, 
secreting keratinocytes with dead keratinocytes or dead kera-
tinous debris in the suspension. Another possible reason might 
be the mechanical stimulation of cells during the complex and 
extended isolation procedure. 
Since Langerhans cells are considered part of the monocyte/ 
macrophage lineage, it is highly likely that these cells are also 
able to contribute to the production of chemotactic arachidon-
ate metabolites. Our present data neither prove nor disprove 
this point. They leave, however, no doubt that keratinocytes 
serve as source of these potent mediators. Since Langerhans 
cells make up at most 5% of our epidermal cells suspensions, 
and since one needs between 5 X 106 and 1 X 107 epidermal 
cells for the generation of sufficient amounts of mediators for 
the bioassay and RP-HPLC analysis, it is not surprising that 
the few Langerhans cells in the suspension do not contribute 
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to the activities measured. The data indicate however that 
these cells have no synergistic interaction with keratinocytes 
in the production of leukotrienes. 
There are several reasons why the chemotactic activity gen-
erated from keratinocytes in the present experiments is thought 
to be arachidonate-derived, lipoxygenase-dependent, and pri-
marily L TB,. These are based on the data on the pharmacologic 
modulation of the release reaction from keratinocytes (Table 
1), on the physicochemical findings, on the coelution of chem-
otacticly active L TB4 (III) with a biologically active peak (Fig 
3), and on the identification of L TB, in the crude and fraction-
ated keratinocyte supernatants by RIA (Fig 4). 
Indomethacin, at doses that are known to inhibit cyclooxy-
genase metabolism of aa [12,16], does not inhibit and it even 
increases the generation of chemotactic activity (Table I). This 
enhancement is due either to more substrate availability for 
the lipoxygenase pathway or to decreased metabolism of the 
biologically active, lipoxygenase-dependent mediators. In con-
trast, an inhibitor that is known to decrease the activity of the 
lipoxygenase, compound BW 755C, markedly suppressed the 
generation of chemotactic activity in both stimulated and spon-
taneously secreting cells (Table 1). 
The keratinocyte-derived chemotactic activity is similar to 
synthetic L TB, in that it is relatively heat resistant and totally 
extractable into ether at pH 3.0. It coelutes with marker peaks 
for LTB4 and 20-0H-LTB4 , and LTB4 is measured in these 
same regions by RIA (Figs 3, 4). Synthetic 20-0H-LTB, has 
about 1/10 and 20-COOH-L TB, 1/wo of the biologic activity of 
the parent compound in our own assay system [17] and in the 
chemokinesis assay described by Ford-Hutchinson et al [18]. 
These oxidation products of L TB, may thus be a means by 
which cells down-modulate the activity of acute-phase, potent 
inflammatory mediators like L TB •. 
The data presented here need to be extended by further 
studies, particularly by analysis of the compounds by mass 
spectroscopy. Such investigations are hampered by the lack of 
availability of large quantities of fresh keratinocytes from hu-
man donors. The identification of chemotactic arachidonate 
metabolites from human keratinocytes, as reported here, never-
theless provides new insights into t he role that these cells may 
play as rapidly responding effector cells and as a first line of 
defense of the host against inflammatory stimuli . 
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